Calcium and bone mineral metabolism in children with chronic illnesses

Annual Review of Nutrition

Volumn 24, Issue , 2004, Pages 13-32

  Abrams, S A ^a   O'Brien, K O ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Bone mass; Medications; Nutrition; Pediatrics; Vitamin D

Indexed keywords

ANTIRETROVIRUS AGENT; BIOLOGICAL MARKER; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CORTICOSTEROID; CYTOKINE; GROWTH FACTOR; GROWTH HORMONE; INFLIXIMAB; PROTEINASE INHIBITOR; VITAMIN D;

BONE MASS; BONE METABOLISM; BONE MINERAL; BONE TURNOVER; CALCIUM ABSORPTION; CALCIUM BALANCE; CALCIUM INTAKE; CALCIUM METABOLISM; CELIAC DISEASE; CHILD; CHOLESTASIS; CHRONIC DISEASE; CHRONIC KIDNEY FAILURE; CYSTIC FIBROSIS; DIET; DISEASE EXACERBATION; DISEASE SEVERITY; ENTERITIS; EXERCISE; HUMAN; MALABSORPTION; METABOLIC BONE DISEASE; NUTRITIONAL SUPPORT; ORGAN TRANSPLANTATION; OSTEOLYSIS; PATHOPHYSIOLOGY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; REVIEW; RHEUMATIC DISEASE; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION;

ADRENAL CORTEX HORMONES; ANTI-HIV AGENTS; BONE AND BONES; BONE DENSITY; BONE DEVELOPMENT; CALCIFICATION, PHYSIOLOGIC; CALCIUM; CALCIUM, DIETARY; CHILD; CHRONIC DISEASE; HUMANS; VITAMIN D;

EID: 3142707100     PISSN: 01999885     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.nutr.24.012003.132135     Document Type: Review

References (87)

1. Deleted in proof
2. Abrams SA. 1999. Using stable isotopes to assess mineral absorption and utilization by children. Am. J. Clin. Nutr. 70:955-64
3. Deleted in proof
4. Allali F, Breban M, Porcher R, Maillefert JF, Dougados M, Roux C. 2003. Increase in bone mineral density of patients with spondyloarthropathy treated with anti-tumour necrosis factor alpha. Ann. Rheum. Dis. 62:347-49
5. American Academy of Pediatrics. 2002. Pediatric organ donation and transplantation: policy statement: organizational principles to guide and define the child health care system and/or improve the health of all children: Committee on Hospital Care and Section on Surgery. Pediatrics 109:982-84
6. Arikoski P, Voutilainen R, Kroger H. 2003. Bone mineral density in long-term survivors of childhood cancer. J. Pediatr. Endocrinol. Metab. 16(Suppl. 2):343-53
7. Aris RM, Lester GE, Dingman S, Ontjes DA. 1999. Altered calcium homeostasis in adults with cystic fibrosis. Osteoporos. Int. 10:102-8
8. Aris RM, Stephens AR, Ontjes DA, Denene BA, Lark RK, et al. 2000. Adverse alterations in bone metabolism are associated with lung infection in adults with cystic fibrosis. Am. J. Respir. Crit. Care Med. 162:1674-78
9. Aukrust P, Haug CJ, Ueland T, Lien E, Muller F, et al. 1999. Decreased bone formative and enhanced resorptive markers in human immunodeficiency virus infection: indication of normalization of the bone-remodeling process during highly active antiretroviral therapy. J. Clin. Endocrinol. Metab. 84:145-50
10. Bahceciler NN, Sezgin G, Nursoy MA, Barlan IB, Basaran MM. 2002. Inhaled corticosteroids and bone density of children with asthma. J. Asthma 39:151-57
11. Baker SS, Cochran WJ, Flores CA, Georgieff MK, Jacobson MS, et al. 1999. American Academy of Pediatrics. Committee on Nutrition. Calcium requirements of infants, children, and adolescents. Pediatrics 104:1152-57
12. Barr SI. 2003. Increased dairy product or calcium intake: Is body weight or composition affected in humans? J. Nutr. 133:2458-488
13. Batch JA, Couper JJ, Rodda C, Cowell CT, Zacharin M. 2003. Use of bisphosphonate therapy for osteoporosis in childhood and adolescence. J. Paediatr. Child Health 39:88-92
14. Bianchi ML, Bardella MT. 2002. Bone and celiac disease. Calcif. Tissue Int. 71:465-71
15. Bianchi ML, Cimaz R, Galbiati E, Corona F, Cherubini R, Bardare M. 1999. Bone mass change during methotrexate treatment in patients with juvenile rheumatoid arthritis. Osteoporos. Int. 10:20-25
16. Bousvaros A, Leichtner A, Zurakowski D, Kwon J, Law T, et al. 1999. Elevated serum vascular endothelial growth factor in children and young adults with Crohn's disease. Dig. Dis. Sci. 44:424-30
17. Bucuvalas JC, Heubi JE, Specker BL, Gregg DJ, Yergey AL, Vieira NE. 1990. Calcium absorption in bone disease associated with chronic cholestasis during childhood. Hepatology 12:1200-5
18. Catassi C, Fasano A. 2002. New developments in childhood celiac disease. Curr. Gastroenterol. Rep. 4:238-43
19. Chad KE, Bailey DA, McKay HA, Zello GA, Snyder RE. 1999. The effect of a weight-bearing physical activity program on bone mineral content and estimated volumetric density in children with spastic cerebral palsy. J. Pediatr. 135:115-17
20. Conway SP. 2001. Impact of lung inflammation on bone metabolism in adolescents with cystic fibrosis. Paediatr. Respir. Rev. 2:324-31
21. D'Souza M. 1998. Comparative review of the effects of inhaled beclomethasone dipropionate and budesonide on bone. Respir. Med. 92(Suppl. B):24-36
22. DeLucia MC, Mitnick ME, Carpenter TO. 2003. Nutritional rickets with normal circulating 25-hydroxyvitamin D: a call for reexamining the role of dietary calcium intake in North American infants. J. Clin. Endocrinol. Metab. 88:3539-45
23. Ellis KJ, Shypailo RJ, Hardin DS, Perez MD, Motil KJ, et al. 2001. Z score prediction model for assessment of bone mineral content in pediatric diseases. J. Bone Miner. Res. 16:1658-64
24. Ellis KJ, Shypailo RJ, Hergenroeder A, Perez M, Abrams S. 1996. Total body calcium and bone mineral content: comparison of dual-energy X-ray absorptiometry with neutron activation analysis. J. Bone Miner. Res. 11:843-48
25. Ferraris JR, Pasqualini T, Legal S, Sorroche P, Galich AM, et al. 2000. Effect of deflazacort versus methylprednisone on growth, body composition, lipid profile, and bone mass after renal transplantation. The Deflazacort Study Group. Pediatr. Nephrol. 14:682-88
26. Fine RN. 2002. Growth following solid-organ transplantation. Pediatr. Transplant. 6:47-52
27. Fogelman I, Blake GM. 2000. Different approaches to bone densitometry. J. Nucl. Med. 41:2015-25
28. French AR, Mason T, Nelson AM, Crowson CS, O'Fallon WM, et al. 2002. Osteopenia in adults with a history of juvenile rheumatoid arthritis. A population based study. J. Rheumatol. 29:1065-70
29. Frost HM, Ferretti JL, Jee WS. 1998. Perspectives: some roles of mechanical usage, muscle strength, and the mechanostat in skeletal physiology, disease, and research. Calcif. Tissue Int. 62:1-7
30. Gilbert L, He X, Farmer P, Boden S, Kozlowski M, et al. 2000. Inhibition of osteoblast differentiation by tumor necrosis factor-alpha. Endocrinology 141:3956-64
31. Gunczler P, Lanes R, Paz-Martinez V, Martins R, Esaa S, et al. 1998. Decreased lumbar spine bone mass and low bone turnover in children and adolescents with insulin dependent diabetes mellitus followed longitudinally. J. Pediatr. Endocrinol. Metab. 11:413-19
32. Guthery SL, Pohl JF, Bucuvalas JC, Alonso MH, Ryckman FC, et al. 2003. Bone mineral density in long-term survivors following pediatric liver transplantation. Liver Transpl. 9:365-70
33. Haapasalo H, Sievanen H, Kannus P, Heinonen A, Oja P, Vuori I. 1996. Dimensions and estimated mechanical characteristics of the humerus after long-term tennis loading. J. Bone Miner. Res. 11:864-72
34. Hahn TJ, Squires AE, Halstead LR, Strominger DB. 1979. Reduced serum 25-hydroxyvitamin D concentration and disordered mineral metabolism in patients with cystic fibrosis. J. Pediatr. 94:38-42
35. Hallberg K, Grzegorczyk A, Larson G, Strandvik B. 1997. Intestinal permeability in cystic fibrosis in relation to genotype. J. Pediatr. Gastroenterol. Nutr. 25:290-95
36. Hamosh A, Fitz-Simmons SC, Macek M Jr, Knowles MR, Rosenstein BJ, Cutting GR. 1998. Comparison of the clinical manifestations of cystic fibrosis in black and white patients. J. Pediatr. 132:255-59
37. Henderson RC, Lark RK, Gurka MJ, Worley G, Fung EB, et al. 2002. Bone density and metabolism in children and adolescents with moderate to severe cerebral palsy. Pediatrics 110:e5
38. Hollander D. 1999. Intestinal permeability, leaky gut, and intestinal disorders. Curr. Gastroenterol. Rep. 1:410-16
39. Hruska K. 2000. Pathophysiology of renal osteodystrophy. Pediatr. Nephrol. 14:636-40
40. Ionescu AA, Nixon LS, Evans WD, Stone MD, Lewis-Jenkins V, et al. 2000. Bone density, body composition, and inflammatory status in cystic fibrosis. Am. J. Respir. Crit. Care Med. 162:789-94
41. Issenman RM. 1999. Bone mineral metabolism in pediatric inflammatory bowel disease. Inflamm. Bowel Dis. 5: 192-99
42. Klein GL, Soriano H, Shulman RJ, Levy M, Jones G, Langman CB. 2002. Hepatic osteodystrophy in chronic cholestasis: evidence for a multifactorial etiology. Pediatr. Transplant. 6:136-40
43. Kotaniemi A, Savolainen A, Kroger H, Kautiainen H, Isomaki H. 1999. Weight-bearing physical activity, calcium intake, systemic glucocorticoids, chronic inflammation, and body constitution as determinants of lumbar and femoral bone mineral in juvenile chronic arthritis. Scand. J. Rheumatol. 28:19-26
44. Koutkia P, Lu Z, Chen TC, Holick MF. 2001. Treatment of vitamin D deficiency due to Crohn's disease with tanning bed ultraviolet B radiation. Gastroenterology 121:1485-88
45. Lu PW, Cowell CT, Lloyd-Jones SA, Briody JN, Howman-Giles R. 1996. Volumetric bone mineral density in normal subjects, aged 5-27 years. J. Clin. Endocrinol. Metab. 81:1586-90
46. Lukert BP. 1999. Glucocorticoid-induced osteoporosis. In Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, ed. MJ Favus, pp. 292-96. Philadelphia: Lippincott
47. Maeno N, Takei S, Imanaka H, Takasaki I, Kitajima I, et al. 1999. Increased circulating vascular endothelial growth factor is correlated with disease activity in polyarticular juvenile rheumatoid arthritis. J. Rheumatol. 26:2244-48
48. Manolagas SC. 2000. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr. Rev. 21:115-37
49. Marcus R. 2001. Role of exercise in preventing and treating osteoporosis. Rheum. Dis. Clin. North Am. 27:131-41, vi
50. Marini JC. 2003. Do bisphosphonates make children's bones better or brittle? N. Engl. J. Med. 349:423-26
51. Masi L, Cimaz R, Simonini G, Bindi G, Stagi S, et al. 2002. Association of low bone mass with vitamin D receptor gene and calcitonin receptor gene polymorphisms in juvenile idiopathic arthritis. J. Rheumatol. 29:2225-31
52. Matkovic V, Heaney RP. 1992. Calcium balance during human growth: evidence for a threshold behavior. Am. J. Clin. Nutr. 55:992-96
53. McColley SA, Stellmach V, Boas SR, Jain M, Crawford SE. 2000. Serum vascular endothelial growth factor is elevated in cystic fibrosis and decreases with treatment of acute pulmonary exacerbation. Am. J. Respir. Crit. Care Med. 161:1877-80
54. Nicolaidou P, Ladefoged K, Hylander E, Thale M, Jarnum S. 1980. Endogenous faecal calcium in chronic malabsorption syndromes and in intestinal lymphangiectasia. Scand. J. Gastroenterol. 15:587-92
55. Niida S, Kaku M, Amano H, Yoshida H, Kataoka H, et al. 1999. Vascular endothelial growth factor can substitute for macrophage colony-stimulating factor in the support of osteoclastic bone resorption. J. Exp. Med. 190:293-98
56. Nysom K, Holm K, Michaelsen KF, Hertz H, Muller J, Molgaard C. 2001. Bone mass after treatment of malignant lymphoma in childhood. Med. Pediatr. Oncol. 37:518-24
57. O'Brien KO, Abrams SA, Stuff JE, Liang LK, Welch TR. 1996. Variables related to urinary calcium excretion in young girls. J. Pediatr. Gastroenterol. Nutr. 23:8-12
58. O'Brien KO, Razavi M, Henderson RA, Caballero B, Ellis KJ. 2001. Bone mineral content in girls perinatally infected with HIV. Am. J. Clin. Nutr. 73:821-26
59. Ott SM, Aitken ML. 1998. Osteoporosis in patients with cystic fibrosis. Clin. Chest Med. 19:555-67
60. Perez MD, Abrams SA, Koenning G, Stuff JE, O'Brien KO, Ellis KJ. 1994. Mineral metabolism in children with dermatomyositis. J. Rheumatol. 21:2364-69
61. Perez MD, Abrams SA, Loddeke L, Shypailo R, Ellis KJ. 2000. Effects of rheumatic disease and corticosteroid treatment on calcium metabolism and bone density in children assessed one year after diagnosis, using stable isotopes and dual energy x-ray absorptiometry. J. Rheumatol. 27(Suppl. 58):38-43
62. Rabinovich CE. 2000. Bone mineral status in juvenile rheumatoid arthritis. J. Rheumatol. 27(Suppl. 58):34-37
63. Rashid M, Durie P, Andrew M, Kalnins D, Shin J, et al. 1999. Prevalence of vitamin K deficiency in cystic fibrosis. Am. J. Clin. Nutr. 70:378-82
64. Roux C, Kolta S, Desfougeres JL, Minini P, Bidat E. 2003. Long-term safety of fluticasone propionate and nedocromil sodium on bone in children with asthma. Pediatrics 111:e706-13
65. Salusky IB. 1995. Bone and mineral metabolism in childhood end-stage renal disease. Pediatr. Clin. North Am. 42:1531-50
66. Sas TC, de Muinck Keizer-Schrama SM, Stijnen T, van Teunenbroek A, van Leeuwen WJ, et al. 2001. Bone mineral density assessed by phalangeal radiographic absorptiometry before and during long-term growth hormone treatment in girls with Turner's syndrome participating in a randomized dose-response study. Pediatr. Res. 50:417-22
67. Schulze KJ, O'Brien KO, Germain-Lee EL, Baer DJ, Leonard AL, Rosenstein BJ. 2003. Endogenous fecal losses of calcium compromise calcium balance in pancreatic-insufficient girls with cystic fibrosis. J. Pediatr. 143:765-71
68. Schulze KJ, O'Brien KO, Germain-Lee EL, Baer DJ, Leonard A, Rosenstein BJ. 2003. Efficiency of calcium absorption is not compromised in clinically stable pre-pubertal and pubertal girls with cystic fibrosis. Am. J. Clin. Nutr. 78:110-16
69. Schurman SJ, Bergstrom WH, Root AW, Souid AK, Hannan WP. 1998. Interleukin 1 beta mediated calciotropic activity in serum of children with juvenile rheumatoid arthritis. J. Rheumatol. 25:161-65
70. Shoemaker LR. 1999. Expanding role of bisphosphonate therapy in children. J. Pediatr. 134:264-67
71. Shore RM, Poznaski AK. 1999. Radiologic evaluation of bone mineral in children. In Primer of the Metabolic Bone Diseases, ed. MJ Favus, pp. 134-46. Philadelphia: Lippincott
72. Simon D. 2002. Puberty in chronically diseased patients. Horm. Res. 57(Suppl. 2):53-56
73. Singer LT, Davillier M, Preuss L, Szekely L, Hawkins S, et al. 1996. Feeding interactions in infants with very low birth weight and bronchopulmonary dysplasia. J. Dev. Behav. Pediatr. 17:69-76
74. Smith SM, Wastney ME, Morukov BV, Larina M, Nyquist LE, et al. 1999. Calcium metabolism before, during, and after a 3-mo spaceflight: kinetic and biochemical changes. Am. J. Physiol. 277:R1-10
75. Specker BL. 2002. Are activity and diet really important for children's bones? Nutr. Today 37:44-49
76. 75a. Stand. Comm. Sci. Eval. Diet. Ref. Intakes, Food Nutr. Board, Inst. Med. 1999. Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. Washington, DC: Natl Acad Press
77. Steelman J, Zeitler P. 2003. Treatment of symptomatic pediatric osteoporosis with cyclic single-day intravenous pamidronate infusions. J. Pediatr. 142:417-23
78. Sullivan PB, Juszczak E, Lambert BR, Rose M, Ford-Adams ME, Johnson A. 2002. Impact of feeding problems on nutritional intake and growth: Oxford Feeding Study II. Dev. Med. Child Neurol. 44:461-67
79. Sylvester FA, Wyzga N, Hyams JS, Gronowicz GA. 2002. Effect of Crohn's disease on bone metabolism in vitro: a role for interleukin-6. J. Bone Miner. Res. 17:695-702
80. Tan BM, Nelson RP Jr, James-Yarish M, Emmanuel PJ, Schurman SJ. 2001. Bone metabolism in children with human immunodeficiency virus infection receiving highly active anti-retroviral therapy including a protease inhibitor. J. Pediatr. 139:447-51
81. Tsekes G, Chrysos G, Douskas G, Paraskeva D, Mangafas N, et al. 2002. Body composition changes in protease inhibitor-naive HIV-infected patients treated with two nucleoside reverse transcriptase inhibitors. HIV Med. 3:85-90
82. Tuckerman K, Hofmaster P, Rosen CJ, Turi M. 2002. Bone density in ambulatory and immobile children. J. Clin. Densitom. 5:327-34
83. Verma A, Maxwell JD, Ang L, Davis T, Hodges S, et al. 2002. Ursodeoxycholic acid enhances fractional calcium absorption in primary biliary cirrhosis. Osteoporos. Int. 13:677-82
84. Waring WW. 1976. Current management of cystic fibrosis. Adv. Pediatr. 23:401-38
85. Whyte MP, Wenkert D, Clements KL, McAlister WH, Mumm S. 2003. Bisphosphonate-induced osteopetrosis. N. Engl. J. Med. 349:457-63
86. Woodcock A. 1998. Effects of inhaled corticosteroids on bone density and metabolism. J. Allergy Clin. Immunol. 101:8456-59
87. Zamboni G, Antoniazzi F, Bertoldo F, Lauriola S, Antozzi L, Tato L. 2003. Altered bone metabolism in children infected with human immunodeficiency virus. Acta Paediatr. 92:12-16